- Home
- NWTG vs CANF Comparison
NWTG vs CANF Comparison
Compare NWTG & CANF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NWTG | CANF |
|---|---|---|
| Founded | 2018 | 1994 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Recreational Games/Products/Toys | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.2M | 6.7M |
| IPO Year | 2022 | 2011 |
Fundamental Metrics
Financial Performance| Metric | NWTG | CANF |
|---|---|---|
| Price | $1.11 | $2.22 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 64.8K | ★ 212.7K |
| Earning Date | 11-12-2026 | 09-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 99.09 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $8,135,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $104.02 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 136.14 | N/A |
| 52 Week Low | $0.70 | $0.17 |
| 52 Week High | $1.97 | $10.40 |
Technical Indicators
Market Signals| Indicator | NWTG | CANF |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 38.34 |
| Support Level | N/A | $2.16 |
| Resistance Level | N/A | $2.39 |
| Average True Range (ATR) | 0.00 | 0.07 |
| MACD | 0.00 | 0.04 |
| Stochastic Oscillator | 0.00 | 44.00 |
Price Performance
Historical ComparisonAbout NWTG Newton Golf Company Inc.
Newton Golf Co Inc is a technology-forward golf company engaged in designing, manufacturing, and selling performance golf equipment, including premium golf shafts and putters, and focuses on developing technology-driven golf products intended to enhance player performance. The company sells its products through e-commerce, distributors, wholesale customers, including pro-shops at golf courses and off-course retailers, sporting goods retailers, online retailers, third-party distributors, and through Club Champion Golf.
About CANF Can-Fite Biopharma Ltd Sponsored ADR (Israel)
Can Fite Biopharma Ltd is a clinical-stage biopharmaceutical company. The company focuses on developing orally bioavailable small-molecule drugs targeting the A3 adenosine receptor for treating cancer, inflammatory diseases, liver disorders, and related conditions. It has a pipeline of proprietary drug candidates in Phase II and Phase III clinical development. The company's platform targets the A3 adenosine receptor (A3AR), which is more expressed in inflammatory and cancerous cells than in normal cells. Its pipeline drugs include Namodenoson, Piclidenoson, CF602, and Cannabinoids.